{"doi":"10.1093/cid/ciad440","title":"Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial","abstract":"BACKGROUND: Amphotericin B is the gold standard treatment for severe mycoses. A new orally delivered, less-toxic formulation of amphotericin has been developed. METHODS: In our randomized clinical trial, we tested oral lipid nanocrystal (LNC) amphotericin B (MAT2203, Matinas Biopharma) vs intravenous (IV) amphotericin for human immunodeficiency virus-associated cryptococcal meningitis in 4 sequential cohorts. Two pilot cohorts assessed safety and tolerability (n = 10 each), and 2 cohorts assessed efficacy with/without 2 IV loading doses (n = 40 each). The experimental arm received 1.8 g/d oral LNC amphotericin through 2 weeks with 100 mg/kg/d flucytosine, then 1.2 g/d LNC amphotericin through 6 weeks. The randomized control arm (n = 41) received 7 days of IV amphotericin with flucytosine, then 7 days of fluconazole 1200 mg/d. The primary end point was cerebrospinal fluid (CSF) early fungicidal activity (EFA). RESULTS: We randomized 80 participants to oral LNC amphotericin + flucytosine with (n = 40) and without (n = 40) 2 IV loading doses and 41 control participants to IV amphotericin + flucytosine. Mean EFA was 0.40 log10 colony-forming units (CFU)/mL/d for all-oral LNC amphotericin, 0.42 log10 Cryptococcus CFU/mL/d for oral LNC amphotericin with IV loading doses, and 0.46 log10 CFU/mL/d for IV amphotericin controls. LNC amphotericin groups achieved 2-week CSF sterility in 63% (44 of 70) vs 68% (23 of 34) of controls. The 18-week survival was 85% (34 of 40) with all-oral LNC amphotericin, 90% (36 of 40) with oral LNC amphotericin given IV loading doses, and 85% (35 of 41) with IV amphotericin.Grade 3-4 laboratory adverse events occurred less frequently in LNC amphotericin groups (41%) than the IV amphotericin group (61%, P = .05), particularly for anemia (21% vs 44%; P = .01) and potassium (5% vs 17%; P = .04). CONCLUSIONS: This new oral amphotericin B LNC formulation appears promising for cryptococcal meningitis with antifungal activity, similar survival, and less toxicity than IV amphotericin. CLINICAL TRIALS REGISTRATION: NCT04031833.","journal":"Clinical Infectious Diseases","year":2023,"id":318428,"datarank":1.3097062554513048,"base_score":4.189654742026425,"endowment":4.189654742026425,"self_citation_contribution":0.6284482113039639,"citation_network_contribution":0.681258044147341,"self_endowment_contribution":0.6284482113039639,"citer_contribution":0.681258044147341,"corpus_percentile":null,"corpus_rank":null,"citation_count":65,"citer_count":41,"citers_with_citation_signal":29,"citers_with_endowment":29,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9486,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT04031833"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":255279,"name":"Mucunguzi Atukunda","orcid":"0000-0003-4762-0728","position":1,"is_corresponding":false},{"id":498936,"name":"Enock Kagimu","orcid":"0000-0002-0291-651X","position":2,"is_corresponding":false},{"id":578702,"name":"Abdu K Musubire","orcid":"0000-0003-2410-5344","position":3,"is_corresponding":false},{"id":732100,"name":"Andrew Akampurira","orcid":null,"position":4,"is_corresponding":false},{"id":452981,"name":"Lillian Tugume","orcid":"0000-0002-1293-1545","position":5,"is_corresponding":false},{"id":452980,"name":"Kenneth Ssebambulidde","orcid":"0000-0002-8125-0698","position":6,"is_corresponding":false},{"id":644484,"name":"John Kasibante","orcid":"0000-0002-7252-4052","position":7,"is_corresponding":false},{"id":922274,"name":"Laura Nsangi","orcid":null,"position":8,"is_corresponding":false},{"id":1025675,"name":"Timothy Mugabi","orcid":"0009-0006-8820-288X","position":9,"is_corresponding":false},{"id":887950,"name":"Jane Gakuru","orcid":"0000-0003-0150-4887","position":10,"is_corresponding":false},{"id":1025676,"name":"Sarah Kimuda","orcid":"0009-0002-1335-9787","position":11,"is_corresponding":false},{"id":1026261,"name":"Derrick Kasozi","orcid":null,"position":12,"is_corresponding":false},{"id":1026262,"name":"Suzan Namombwe","orcid":null,"position":13,"is_corresponding":false},{"id":1026263,"name":"Isaac Turyasingura","orcid":null,"position":14,"is_corresponding":false},{"id":644485,"name":"Morris K Rutakingirwa","orcid":"0000-0003-2276-360X","position":15,"is_corresponding":false},{"id":910489,"name":"Edward Mpoza","orcid":"0000-0001-8469-537X","position":16,"is_corresponding":false},{"id":1025677,"name":"Enos Kigozi","orcid":"0009-0005-4503-4719","position":17,"is_corresponding":false},{"id":399943,"name":"Conrad Muzoora","orcid":"0000-0002-7866-5198","position":18,"is_corresponding":false},{"id":735381,"name":"Jayne Ellis","orcid":"0000-0002-7009-9144","position":19,"is_corresponding":false},{"id":267647,"name":"Caleb P Skipper","orcid":"0000-0002-0000-8876","position":20,"is_corresponding":false},{"id":895305,"name":"Theresa Matkovits","orcid":"0009-0003-3761-9149","position":21,"is_corresponding":false},{"id":342098,"name":"Peter R. Williamson","orcid":"0000-0002-7953-2178","position":22,"is_corresponding":false},{"id":269371,"name":"Darlisha A Williams","orcid":null,"position":23,"is_corresponding":false},{"id":444819,"name":"Ann Fieberg","orcid":null,"position":24,"is_corresponding":false},{"id":329388,"name":"Kathy Huppler Hullsiek","orcid":"0000-0002-2754-3473","position":25,"is_corresponding":false},{"id":267660,"name":"Mahsa Abassi","orcid":"0000-0001-9601-3006","position":26,"is_corresponding":false},{"id":1025678,"name":"Biyue Dai","orcid":"0000-0002-4747-3687","position":27,"is_corresponding":false},{"id":397657,"name":"David B. Meya","orcid":"0000-0002-8854-0321","position":28,"is_corresponding":false},{"id":267658,"name":"David R. Boulware","orcid":"0000-0002-4715-0060","position":0,"is_corresponding":true}],"reference_count":23,"raw_metadata":null,"created_at":"2026-07-19T01:07:01.300821Z","pmid":"37606364","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}